Events and Networking

Expand Your Network at One of Biocom’s 150+ Annual Events

Hear From Young Professionals in Life Science Who Are Redefining Success & Paving the Way

When

Thu Sep 07 00:00:00 GMT 2017 - Thu Sep 07 02:30:00 GMT 2017

Where

The Alexandria
10996 Torreyana Road
San Diego, CA 92121

Register

Hear From Young Professionals in Life Science Who Are Redefining Success & Paving the Way

Biocom’s Life Science Young Leaders Series invites you to join us on Wednesday, September 6th, as we hear from young entrepreneurs redefining success in San Diego, and beyond. The life science industry is a hotbed of entrepreneurship, so it’s no wonder that many of our companies are led by young professionals. Whether you are a seasoned business owner, a recent graduate, or simply a young professional seeking some inspiration in the workplace, we invite you to join us as we learn how some of San Diego’s well known young leaders have forged successful careers in an ever-changing industry.

Moderator: 
Abegale Flores Colmenar, Director of Operations, BioLabs San Diego

Panelists:
Francie Barron, PhD, 
VP Biology & Regulatory Affairs, Nanomedical Diagnostics
Taylor Moyer, CEO, Managed Lab Services 
Aboli Rane, Senior Product Manager, Illumina
Ryan Taft, Senior Director, Scientific Research, Illumina

Agenda
5:00 pm to 5:30 pm | Event Registration
5:30 pm to 6:15 pm | Panel Discussion
6:15 pm to 6:30 pm| Audience Q&A
6:30 pm to 7:30 pm | Networking

*Please note: This event series is closed to any service provider company that is not a member of Biocom, with the exception of event sponsors. In the event that you register, we will need to cancel and refund your registration ticket. If you are interested in learning more about sponsorship, please contact Angela Wieszchowski at angelaw@biocom.org

Price of Admission

Biocom Member

Today's Price: 30.0

Important Dates

Amount

Registration Before Sat Aug 12 00:00:00 GMT 2017

20.0

Registration Before

Registration Before

Refund after Thu Jun 29 00:00:00 GMT 2017

0.0

Refund after

Refund after

Non-Member (Industry Company Only)

Today's Price: 50.0

Important Dates

Amount

Registration Before Sat Aug 12 00:00:00 GMT 2017

40.0

Registration Before

Registration Before

Refund after Thu Jun 29 00:00:00 GMT 2017

0.0

Refund after

Refund after

  • Speaker Bios

    Taylor Moyer- CEO, Managed Lab Services​

    Taylor Moyer is the CEO of ManagedLab Services, a lab services company she founded in March 2008.
    Prior to founding the Company, Mrs. Moyer started her career as a Lab Manager for Applied Molecular Evolution in 2002.  She then cut her teeth in distribution working as a procurement associate for Fisher Scientific.  She then transitioned into the role of Southwest Territory Sales Manager for Biohit, Inc. where she rounded out her supply chain background and stayed until founding ManagedLab.

     In addition to her work with ManagedLab, Mrs. Moyer is also a current board member and President of both the San Diego Entrepreneurs Exchange, a local 501c3 organization whose purpose is providing support for entrepreneurs in the life sciences industry, and Boots in Bio, another non-profit dedicated to training and placing veterans into careers in biotech.  She is a graduate of the University of San Diego with a Bachelors of Arts degree in Biology.

    Francie Barron, PhD, VP Biology & Regulatory Affairs, Nanomedical Diagnostics


    Spearheading biology research and regulatory affairs at Nanomedical Diagnostics, Dr. Barron earned her PhD in Cell Biology, Stem Cells and Development at the University of Colorado Denver Anschutz Medical Campus. Dr. Barron brings 19 years of research experience in academic, pharmaceutical, and regulatory settings to her role optimizing biological systems and directing regulatory strategies for clinical products. At the Ludwig Institute for Cancer Research, Dr. Barron produced over 50 novel antibodies for C. elegans. In her graduate work, Dr. Barron elucidated the signaling pathway by which Hand2 influences lower jaw and tongue development in mice. As a postdoc at Stanford with a NIH training grant award, she worked to develop a new in vitro drug screening process to assess the safety of novel compounds on iPSC-derived human cardiomyocytes. Dr. Barron received an honorable mention in the 2016 Biocom Innovators Under the Age of 40 competition and is excited to bring Nanomedical Diagnostics’ clinical products through the FDA to market.

    Aboli Rane, Senior Product Manager, Illumina
    Aboli Rane is Senior Product Manager at Illumina for the NovaSeq Platform, where she most recently led the Commercial team in the design, development and launch of industry’s highest throughput sequencer. Prior to that she was the Product Manager for Illumina’s $650M HiSeq sequencing consumables business. Aboli has established herself as a cross-functional leader serving pivotal roles within Global Marketing, R&D and Consumables Operations at Illumina. In her 5 years with the company, she has launched the Novaseq 6000™ System and Consumables, HiSeq 3000/4000™ Consumables and cBot 2 Cluster Generation™ platforms as well as led the Operations team for the introduction of the HiSeq 2500™ High Output system. In addition, she spearheaded the digital microfluidics technology transfer following Illumina’s acquisition of Advanced Liquid Logic.

    Prior to Illumina, Aboli was at University of California San Diego where she completed her Ph.D. in Bioengineering studying biomaterial therapies for the treatment of myocardial infarction.  She also has B.S. in Chemical Engineering with a minor in Biomedical Engineering from Cornell University.  Aboli has been awarded numerous accolades including the National Science Foundation fellowship and is the first non-clinician to receive the American Heart Association Women in Cardiology Trainee Award for Excellence.  Aboli is as active member of Athena San Diego, she serves on the committee for Life Sciences and has recently been elected as an Associate Board Member for the 2018 term.  She also led the San Diego chapter of the non-profit organization Asha for Education for 4 years and believes in the power of education and mentorship as a vehicle for change. 

    Ryan J. Taft, PhD, Senior Director, Scientific Research, Illumina, Inc.
     

    Ryan J. Taft, PhD, is Senior Director of Scientific Research at Illumina, with a focus on the development and deployment of diagnostic whole genome sequencing for patients with rare and undiagnosed genetic disease. He leads a team within Clinical Genomics Research whose activities include rapid whole genome clinical testing, multiple clinical trials and software and bioinformatic prototyping and development.
     
    Previously, Dr. Taft was a Group Leader & Senior Research Fellow at the University of Queensland, and he is Adjunct Associate Professor at the George Washington University School of Medicine and Health Sciences. He has published more than 50 peer-reviewed articles in a variety of well-regarded journals, and has led or contributed to teams responsible for the discovery of seven genetic conditions.
     
    Dr. Taft holds various positions within industry organizations. He is a founding member of the Global Leukodystrophy Initiative (GLIA); scientific advisor to the Mission Massimo Foundation; and, co-chair of the Medical and Scientific Advisory Board of Global Genes.
     
    He obtained his Bachelor of Science in Biochemistry and Molecular Biology from the University of California, Davis on a Regent’s Scholarship, and his PhD in Genomics and Computational Biology, which received a Deans’ Commendation for Academic Excellence, from the University of Queensland on a US National Science Graduate Foundation Research Fellowship.
     
     
     

    a0d2A00000DUUi1QAH

    Go
  • Speaker Bios

    Taylor Moyer- CEO, Managed Lab Services​

    Taylor Moyer is the CEO of ManagedLab Services, a lab services company she founded in March 2008.
    Prior to founding the Company, Mrs. Moyer started her career as a Lab Manager for Applied Molecular Evolution in 2002.  She then cut her teeth in distribution working as a procurement associate for Fisher Scientific.  She then transitioned into the role of Southwest Territory Sales Manager for Biohit, Inc. where she rounded out her supply chain background and stayed until founding ManagedLab.

     In addition to her work with ManagedLab, Mrs. Moyer is also a current board member and President of both the San Diego Entrepreneurs Exchange, a local 501c3 organization whose purpose is providing support for entrepreneurs in the life sciences industry, and Boots in Bio, another non-profit dedicated to training and placing veterans into careers in biotech.  She is a graduate of the University of San Diego with a Bachelors of Arts degree in Biology.

    Francie Barron, PhD, VP Biology & Regulatory Affairs, Nanomedical Diagnostics


    Spearheading biology research and regulatory affairs at Nanomedical Diagnostics, Dr. Barron earned her PhD in Cell Biology, Stem Cells and Development at the University of Colorado Denver Anschutz Medical Campus. Dr. Barron brings 19 years of research experience in academic, pharmaceutical, and regulatory settings to her role optimizing biological systems and directing regulatory strategies for clinical products. At the Ludwig Institute for Cancer Research, Dr. Barron produced over 50 novel antibodies for C. elegans. In her graduate work, Dr. Barron elucidated the signaling pathway by which Hand2 influences lower jaw and tongue development in mice. As a postdoc at Stanford with a NIH training grant award, she worked to develop a new in vitro drug screening process to assess the safety of novel compounds on iPSC-derived human cardiomyocytes. Dr. Barron received an honorable mention in the 2016 Biocom Innovators Under the Age of 40 competition and is excited to bring Nanomedical Diagnostics’ clinical products through the FDA to market.

    Aboli Rane, Senior Product Manager, Illumina
    Aboli Rane is Senior Product Manager at Illumina for the NovaSeq Platform, where she most recently led the Commercial team in the design, development and launch of industry’s highest throughput sequencer. Prior to that she was the Product Manager for Illumina’s $650M HiSeq sequencing consumables business. Aboli has established herself as a cross-functional leader serving pivotal roles within Global Marketing, R&D and Consumables Operations at Illumina. In her 5 years with the company, she has launched the Novaseq 6000™ System and Consumables, HiSeq 3000/4000™ Consumables and cBot 2 Cluster Generation™ platforms as well as led the Operations team for the introduction of the HiSeq 2500™ High Output system. In addition, she spearheaded the digital microfluidics technology transfer following Illumina’s acquisition of Advanced Liquid Logic.

    Prior to Illumina, Aboli was at University of California San Diego where she completed her Ph.D. in Bioengineering studying biomaterial therapies for the treatment of myocardial infarction.  She also has B.S. in Chemical Engineering with a minor in Biomedical Engineering from Cornell University.  Aboli has been awarded numerous accolades including the National Science Foundation fellowship and is the first non-clinician to receive the American Heart Association Women in Cardiology Trainee Award for Excellence.  Aboli is as active member of Athena San Diego, she serves on the committee for Life Sciences and has recently been elected as an Associate Board Member for the 2018 term.  She also led the San Diego chapter of the non-profit organization Asha for Education for 4 years and believes in the power of education and mentorship as a vehicle for change. 

    Ryan J. Taft, PhD, Senior Director, Scientific Research, Illumina, Inc.
     

    Ryan J. Taft, PhD, is Senior Director of Scientific Research at Illumina, with a focus on the development and deployment of diagnostic whole genome sequencing for patients with rare and undiagnosed genetic disease. He leads a team within Clinical Genomics Research whose activities include rapid whole genome clinical testing, multiple clinical trials and software and bioinformatic prototyping and development.
     
    Previously, Dr. Taft was a Group Leader & Senior Research Fellow at the University of Queensland, and he is Adjunct Associate Professor at the George Washington University School of Medicine and Health Sciences. He has published more than 50 peer-reviewed articles in a variety of well-regarded journals, and has led or contributed to teams responsible for the discovery of seven genetic conditions.
     
    Dr. Taft holds various positions within industry organizations. He is a founding member of the Global Leukodystrophy Initiative (GLIA); scientific advisor to the Mission Massimo Foundation; and, co-chair of the Medical and Scientific Advisory Board of Global Genes.
     
    He obtained his Bachelor of Science in Biochemistry and Molecular Biology from the University of California, Davis on a Regent’s Scholarship, and his PhD in Genomics and Computational Biology, which received a Deans’ Commendation for Academic Excellence, from the University of Queensland on a US National Science Graduate Foundation Research Fellowship.
     
     
     

    a0d2A00000DUUi1QAH
    Go

Register